Breaking News

Metrics Founder Retires

November 12, 2013

Hodges to pursue other interests

president and founder, Phil Hodges, will retire after 19 years with the company. The company opened in 1994 as a small contract analytical lab with four employees and has since grown to more than 300. The company now offers first-time-in-man development, Phase I, II and III clinical trial materials, as well as full analytical methods development and validation from its custom-built 100,000 sq.-ft. facility in Greenville, NC, which includes a highly potent products containment suite. Last year, Metrics was acquired by Mayne Pharma, a pharmaceutical company based in Melbourne, Australia.

“I built this business and I am proud of it,” said Mr. Hodges, “And that’s what I loved about the Mayne deal, they really got it, they understood what we are doing here. But I’ll be honest, after 19 years, I’m ready to get out of day-today operations and go do something different.” Mr. Hodges will continue to serve on the board of directors at Mayne Pharma.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important